The ink was hardly dried on the paperwork for Thermo Fisher Scientific Inc.‘s deal to acquire German in-vitro diagnostics maker B.R.A.H.M.S. AG for roughly $470 million before the union’s first product hit the market.
Mergers & Acquisitions
Thermo Fisher goes Down Under, buys out Biolab for $120 million
Laboratory instruments giant Thermo Fisher Scientific took a step toward shoring up some softness in its analytic technologies business with its $120 million acquisition of Australia-based Biolab.
The deal extends the Waltham-based firm’s reach into the antipodes, as Biolab has a significant presence in Australia and New Zealand.
Medtronic acquires Ablation Frontiers
MEDTRONIC COMPLETES ACQUISITION OF ABLATION FRONTIERS MINNEAPOLIS AND CARLSBAD, CALIF.
– Feb. 6, 2009 – Medtronic, Inc. (NYSE: MDT), today announced it has through an affiliated entity, completed the acquisition of privately held Ablation Frontiers, Inc. Under the terms of the agreement announced Jan. 12, 2009, the transaction includes an initial payment of $225 million plus potential additional payments contingent upon achievement of certain clinical milestones.
